Arcus Biosciences Financial Overview
Arcus Biosciences's market cap is currently $2.72B. The company's EPS TTM is $-1.27; its P/E ratio is -6.41; Arcus Biosciences is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is $-1.13. See an overview of income statement, balance sheet, and cash flow financials.
